PUBLIC COMPANY
saveAISA Pharma Inc
founded 2017 · 5 employees · Boston, MA, USupdated 1mo ago
Aisa Pharma is a privately held clinical-stage biopharmaceutical company developing repurposed oral therapies for rare serious diseases, with a lead program in Raynaud's phenomenon associated with systemic sclerosis. Its lead candidate AISA-021 is a fixed-dose combination of cilnidipine and tadalafil and has received FDA orphan drug designation for systemic sclerosis.
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
comments(0)
5-min edit window · permanent after that